Invariant natural killer T cell-based immunotherapy for cancer

Immunotherapy
Shinichiro Motohashi, T Nakayama

Abstract

Human Valpha24 invariant natural killer T (iNKT) cells are a distinct lymphocyte population, characterized by an invariant T-cell receptor Valpha24 chain paired mainly with Valpha11. Valpha24 iNKT cells are activated by a glycolipid ligand - alpha-galactosylceramide - and produce a large amount of Th1 and Th2 cytokines, thereby modulating the function of other cells. iNKT cells have the capability to control a wide variety of immune responses, including antitumor immunity. Abnormalities in the number and function of Valpha24 iNKT cells have been observed in patients with malignant diseases accompanied with a poor clinical outcome. Therefore, therapeutic strategies that focused on the restoration of Valpha24 iNKT cell population and function would be a reasonable rationale for the treatment of cancer. In this article, the progress to date in the clinical studies of iNKT cell-based immunotherapy is briefly reviewed and the role of Valpha24 iNKT cells in cancer immunotherapy is highlighted.

References

Jun 9, 1995·Journal of Medicinal Chemistry·M MoritaH Fukushima
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KawanoM Taniguchi
Oct 23, 1998·The Journal of Experimental Medicine·F M SpadaS A Porcelli
Nov 28, 2000·European Journal of Immunology·F M SpadaS A Porcelli
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S M TahirM A Exley
Mar 6, 2002·The Journal of Experimental Medicine·Jenny E GumperzMichael B Brenner
Mar 6, 2002·The Journal of Experimental Medicine·Peter T LeeAlbert Bendelac
May 3, 2002·Japanese Journal of Cancer Research : Gann·Yasunori AkutsuMasaru Taniguchi
Aug 3, 2002·Nature Immunology·Shin-ichiro FujiiRalph M Steinman
Oct 18, 2002·International Journal of Cancer. Journal International Du Cancer·Shinichiro MotohashiMasaru Taniguchi
Jan 25, 2003·Annual Review of Immunology·Masaru TaniguchiHiroshi Wakao
Mar 27, 2003·Nature Reviews. Immunology·S Brian Wilson, Terry L Delovitch
Jun 11, 2003·The Journal of Experimental Medicine·Madhav V DhodapkarJoseph Krasovsky
Jul 9, 2003·The Journal of Experimental Medicine·Dianna Y WuPaul B Chapman
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ian F HermansVincenzo Cerundolo
Nov 26, 2003·Nature Immunology·Masaru TaniguchiToshinori Nakayama
Feb 26, 2004·Journal of Immunological Methods·Paul R RogersShinichiro Kato
Mar 18, 2004·International Journal of Cancer. Journal International Du Cancer·Kavita M DhodapkarRalph M Steinman
Mar 23, 2004·Annual Review of Immunology·Manfred Brigl, Michael B Brenner
May 5, 2004·The Journal of Experimental Medicine·Leonid S MetelitsaRobert C Seeger
Jun 23, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hans J J van der VlietRik J Scheper
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aki IshikawaTakehiko Fujisawa
Mar 10, 2005·International Journal of Cancer. Journal International Du Cancer·Johan W MollingAlfons J M van den Eertwegh
Mar 18, 2005·Annual Review of Immunology·Mitchell Kronenberg
Mar 26, 2005·Nature·Yuki KinjoMitchell Kronenberg
May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Eiichi IshikawaToshinori Nakayama
Aug 9, 2005·Immunology Letters·Karl O A Yu, Steven A Porcelli
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adam P UldrichDale I Godfrey
Sep 3, 2005·The Journal of Clinical Investigation·Vrajesh V ParekhLuc Van Kaer
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Satoshi KojoMasaru Taniguchi
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsuyoshi TachibanaMasayuki Imamura
Nov 9, 2005·The Journal of Experimental Medicine·Nadine Y CroweMark J Smyth
Oct 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shinichiro MotohashiToshinori Nakayama
Dec 8, 2006·Annual Review of Immunology·Albert BendelacLuc Teyton

❮ Previous
Next ❯

Citations

Apr 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alan MelcherJohn C Bell
Feb 18, 2014·Journal of Translational Medicine·Martin WilhelmVolker Kunzmann
Mar 8, 2011·Natural Product Reports·Ilona ChlubnováVincent Ferrières
Feb 19, 2013·Cytotherapy·Simon F Lacey, Michael Kalos
May 9, 2012·Transplantation Proceedings·Y LiuM Li
Feb 26, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Shinichiro MotohashiToshinori Nakayama
Jun 26, 2012·Chembiochem : a European Journal of Chemical Biology·Ming-Han HsiehPi-Hui Liang
Feb 5, 2015·Cytokine·Heather M BuechelLouise M D'Cruz
Jun 11, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elodie Macho-FernandezChristelle Faveeuw

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
flow cytometry
surgical resection

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.